{
    "eid": "2-s2.0-84969667316",
    "title": "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial",
    "cover-date": "2016-08-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Immunology",
            "@code": "2403"
        },
        {
            "$": "Epidemiology",
            "@code": "2713"
        },
        {
            "$": "Virology",
            "@code": "2406"
        }
    ],
    "keywords": [],
    "authors": [
        "Torsak Bunupuradah"
    ],
    "citedby-count": 26,
    "ref-count": 22,
    "ref-list": [
        "Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach",
        "Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study",
        "Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: Final results of the SLOAT trial",
        "Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study",
        "Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin",
        "Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients",
        "Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients",
        "Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults",
        "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults",
        "Pharmacokinetics of low-dose protease inhibitors and efavirenz in low-and middle-income countries",
        "Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand",
        "Assessing adherence in Thai patients taking combination antiretroviral therapy",
        "Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial",
        "Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: A randomized clinical trial",
        "Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-na\u00efve volunteers infected with HIV-1: A Randomized, controlled equivalence trial",
        "Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents",
        "Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study",
        "Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial",
        "Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients",
        "A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study",
        "J AIDS Clin Res"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "affilname": "National Health Security Office",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Bangkok Metropolitan Administration",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "affilname": "Chonburi Regional Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Prapokklao Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "affilname": "The Kirby Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Nontaburi",
            "affilname": "Bamrasnaradura Infectious Disease Institute",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Taksin Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen Regional Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Amsterdam",
            "affilname": "Universiteit van Amsterdam",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Nakhon Phatom Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "affilname": "Sanpatong Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Rai",
            "affilname": "Chiangrai Prachanukroh Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rayong",
            "affilname": "Rayong Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "affilname": "Pranangklao Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Kirby Institute for Infection and Immunity in Society",
        "National Health Security Office"
    ]
}